These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 16356486)
1. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients. Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486 [TBL] [Abstract][Full Text] [Related]
2. Definition of tumor-associated antigens in hepatocellular carcinoma. Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):285-90. PubMed ID: 10750667 [TBL] [Abstract][Full Text] [Related]
3. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma. Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375 [TBL] [Abstract][Full Text] [Related]
4. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma. Uemura M; Nouso K; Kobayashi Y; Tanaka H; Nakamura S; Higashi T; Ono T; Nakayama E; Hanafusa T; Shiratori Y Cancer; 2003 May; 97(10):2474-9. PubMed ID: 12733146 [TBL] [Abstract][Full Text] [Related]
5. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876 [TBL] [Abstract][Full Text] [Related]
6. Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinoma. Wang HC; Su YR; Han KJ; Pang XW; Peng JR; Liang B; Wang S; Chen WF Biochem Cell Biol; 2004 Apr; 82(2):321-7. PubMed ID: 15060627 [TBL] [Abstract][Full Text] [Related]
7. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies. Chen X; Fu S; Chen F; Chen H; Chen Z Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843 [TBL] [Abstract][Full Text] [Related]
8. Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization. Kashiwagi M; Ikeda Y; Iwamori M; Toda G; Nagai Y Cancer Res; 1989 Aug; 49(16):4396-401. PubMed ID: 2545342 [TBL] [Abstract][Full Text] [Related]
9. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma. Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253 [TBL] [Abstract][Full Text] [Related]
10. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma. Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810 [TBL] [Abstract][Full Text] [Related]
11. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336 [TBL] [Abstract][Full Text] [Related]
12. [Screening and analysis of genes encoding hepatocellular carcinoma associated tumor antigens]. Wang HC; Yang MH; Shi YY; Pang XW; Yang XA; Peng JR; Leng XS; Chen WF Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):343-6. PubMed ID: 15918967 [TBL] [Abstract][Full Text] [Related]
13. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715 [TBL] [Abstract][Full Text] [Related]
14. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma. Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540 [TBL] [Abstract][Full Text] [Related]
15. Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients. Bei R; Budillon A; Reale MG; Capuano G; Pomponi D; Budillon G; Frati L; Muraro R Cancer Res; 1999 Nov; 59(21):5471-4. PubMed ID: 10554020 [TBL] [Abstract][Full Text] [Related]
16. A new tumor-associated antigen useful for serodiagnosis of hepatocellular carcinoma, defined by monoclonal antibody KM-2. Kumagai Y; Chiba J; Sata T; Ohtaki S; Mitamura K Cancer Res; 1992 Sep; 52(18):4987-94. PubMed ID: 1381274 [TBL] [Abstract][Full Text] [Related]
18. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. Himoto T; Kuriyama S; Zhang JY; Chan EK; Nishioka M; Tan EM Int J Oncol; 2005 Feb; 26(2):311-7. PubMed ID: 15645114 [TBL] [Abstract][Full Text] [Related]
19. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326 [TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Harada T; Fujimoto M; Sakaida I; Okita K; Oka M; Nakamura K Proteomics; 2006 Jul; 6(13):3894-900. PubMed ID: 16767786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]